Evidence map›Paper›PMID 27188339›Full record

ReviewNature reviews. Disease primers2016

Erectile dysfunction.

Faysal A Yafi, Lawrence Jenkins, Maarten Albersen, Giovanni Corona, Andrea M Isidori, Shari Goldfarb, Mario Maggi, Christian J Nelson, Sharon Parish, Andrea Salonia and 3 more

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Disease primers, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 405 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
405citing papers in PubMed, 8 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06397612 naactive not recruitingnot on this mapstarted 2023, after this paper: background citation

Registry on the Short- and Medium-term Efficacy of Low-dose Peripheral Nerve Stimulation of the Pudendal Nerve in Patients With Pudendal Nerve in Patients With Erectile Dysfunction

TypeinterventionalSponsorCamilo Jose Cela UniversityRan2023 to 2026Enrolled24ConditionsPudendal Nerve Injury, Erectile Dysfunction, Electric StimulationArmsLow Dose
NCT06397625 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Short- and Medium-term Efficacy of Treatment With Peripheral Nerve Stimulation of the Pudendal Nerve in Patients With Erectile Dysfunction: a Randomized Clinical Trial

TypeinterventionalSponsorCamilo Jose Cela UniversityRan2024 to 2026Enrolled72ConditionsErectile Dysfunction, Electric Stimulation, Pudendal NerveArmsPercutaneous electrical neurostimulation (Placebo), Percutaneous electrical neurostimulation
3 · Its place in the literature

Who cites it

405 citing papers in PubMed, 8 syntheses or guidelines pooled it, 750 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Low-intensity shockwave therapy for erectile dysfunction.The Cochrane database of systematic reviews · 2025
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

345 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 4 countries.

Faysal A YafiTulane University School of Medicine, Department of Urology, Box SL 42, 1430 Tulane Avenue, New Orleans, Louisiana 70112-2699, USA.
Lawrence JenkinsSexual and Reproductive Medicine Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Maarten AlbersenLaboratory for Experimental Urology, Gene and Stem Cells Applications, Department of Development and Regeneration, University of Leuven, Leuven, Belgium.
Giovanni CoronaEndocrinology Unit, Maggiore-Bellaria Hospital, Bologna, Italy.
Andrea M IsidoriDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Shari GoldfarbDepartment of Psychiatry &Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Mario MaggiSexual Medicine and Andrology Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.
Christian J NelsonDepartment of Psychiatry &Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Sharon ParishDepartment of Medicine, Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Andrea SaloniaDivision of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.
Ronny TanDepartment of Urology, Tan Tock Seng Hospital, Singapore.
John P MulhallSexual and Reproductive Medicine Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Wayne J G HellstromTulane University School of Medicine, Department of Urology, Box SL 42, 1430 Tulane Avenue, New Orleans, Louisiana 70112-2699, USA.
Memorial Sloan Kettering Cancer Center · USTulane University · USAlbert Einstein College of Medicine · USIRCCS Ospedale San Raffaele · ITKU Leuven · BEOspedale Bellaria · ITSapienza University of Rome · ITTan Tock Seng Hospital · SGUniversity of Florence · IT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Erectile dysfunction is a multidimensional but common male sexual dysfunction that involves an alteration in any of the components of the erectile response, including organic, relational and psychological. Roles for nonendocrine (neurogenic, vasculogenic and iatrogenic) and endocrine pathways have been proposed. Owing to its strong association with metabolic syndrome and cardiovascular disease, cardiac assessment may be warranted in men with symptoms of erectile dysfunction. Minimally invasive interventions to relieve the symptoms of erectile dysfunction include lifestyle modifications, oral drugs, injected vasodilator agents and vacuum erection devices. Surgical therapies are reserved for the subset of patients who have contraindications to these nonsurgical interventions, those who experience adverse effects from (or are refractory to) medical therapy and those who also have penile fibrosis or penile vascular insufficiency. Erectile dysfunction can have deleterious effects on a man's quality of life; most patients have symptoms of depression and anxiety related to sexual performance. These symptoms, in turn, affect his partner's sexual experience and the couple's quality of life. This Primer highlights numerous aspects of erectile dysfunction, summarizes new treatment targets and ongoing preclinical studies that evaluate new pharmacotherapies, and covers the topic of regenerative medicine, which represents the future of sexual medicine.

Indexed as

AgingAlcohol DrinkingEndocrine System DiseasesErectile DysfunctionHumansMalePenisQuality of LifeRisk FactorsSmoking

Identifiers

PMID27188339
PMCPMC5027992
OpenAlexW4211157510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.